Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients

Emanuele Focà; Andrea CALCAGNO; Andrea Bonito; MARCO SIMIELE; Elisabetta Domenighini; ANTONIO D'AVOLIO; Eugenia Quiros Roldan; Laura TRENTINI; Salvatore Casari; Giovanni DI PERRI; Francesco Castelli; Stefano BONORA

doi:10.1093/jac/dkx274

Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients

Emanuele Focà
, Andrea CALCAGNO
, Andrea Bonito
, MARCO SIMIELE
, Elisabetta Domenighini
, ANTONIO D'AVOLIO
, Eugenia Quiros Roldan
, Laura TRENTINI
, Salvatore Casari
, Giovanni DI PERRI
, Francesco Castelli
, Stefano BONORA

Department of Translational Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Atazanavir (300 mg) boosted by ritonavir (100 mg) is the preferred third drug in pregnancy. However, there is still discordance on atazanavir dose increase during the third trimester.

Original language	English
Pages (from-to)	3163-3166
Number of pages	4
Journal	Journal of Antimicrobial Chemotherapy
Volume	72
Issue number	11
DOIs	https://doi.org/10.1093/jac/dkx274
Publication status	Published - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1093/jac/dkx274

https://hdl.handle.net/11579/216863

Cite this

Focà, E., CALCAGNO, A., Bonito, A., SIMIELE, MARCO., Domenighini, E., D'AVOLIO, ANTONIO., Quiros Roldan, E., TRENTINI, L., Casari, S., DI PERRI, G., Castelli, F., & BONORA, S. (2017). Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients. Journal of Antimicrobial Chemotherapy, 72(11), 3163-3166. https://doi.org/10.1093/jac/dkx274

@article{ca3948dd312c46dfa58d8e4bbf20e1ed,

title = "Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients",

abstract = "Atazanavir (300 mg) boosted by ritonavir (100 mg) is the preferred third drug in pregnancy. However, there is still discordance on atazanavir dose increase during the third trimester.",

author = "Emanuele Foc{\`a} and Andrea CALCAGNO and Andrea Bonito and MARCO SIMIELE and Elisabetta Domenighini and ANTONIO D'AVOLIO and \{Quiros Roldan\}, Eugenia and Laura TRENTINI and Salvatore Casari and \{DI PERRI\}, Giovanni and Francesco Castelli and Stefano BONORA",

year = "2017",

doi = "10.1093/jac/dkx274",

language = "English",

volume = "72",

pages = "3163--3166",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "11",

}

Focà, E, CALCAGNO, A, Bonito, A, SIMIELE, MARCO, Domenighini, E, D'AVOLIO, ANTONIO, Quiros Roldan, E, TRENTINI, L, Casari, S, DI PERRI, G, Castelli, F & BONORA, S 2017, 'Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients', Journal of Antimicrobial Chemotherapy, vol. 72, no. 11, pp. 3163-3166. https://doi.org/10.1093/jac/dkx274

TY - JOUR

T1 - Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients

AU - Focà, Emanuele

AU - CALCAGNO, Andrea

AU - Bonito, Andrea

AU - SIMIELE, MARCO

AU - Domenighini, Elisabetta

AU - D'AVOLIO, ANTONIO

AU - Quiros Roldan, Eugenia

AU - TRENTINI, Laura

AU - Casari, Salvatore

AU - DI PERRI, Giovanni

AU - Castelli, Francesco

AU - BONORA, Stefano

PY - 2017

Y1 - 2017

N2 - Atazanavir (300 mg) boosted by ritonavir (100 mg) is the preferred third drug in pregnancy. However, there is still discordance on atazanavir dose increase during the third trimester.

AB - Atazanavir (300 mg) boosted by ritonavir (100 mg) is the preferred third drug in pregnancy. However, there is still discordance on atazanavir dose increase during the third trimester.

UR - https://iris.uniupo.it/handle/11579/216863

U2 - 10.1093/jac/dkx274

DO - 10.1093/jac/dkx274

M3 - Article

SN - 0305-7453

VL - 72

SP - 3163

EP - 3166

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

IS - 11

ER -

Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this